Bicara Therapeutics Inc. ... (BCAX)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

17.25

-1.71%

After-hours Dec 13, 2024, 05:48 PM EST

Bicara Therapeutics Inc. Common Stock Forcast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for BCAX stock have an median target of 42, with a low estimate of 35 and a high estimate of 47. The median target predicts an increase of 139.32% from the current stock price of 17.55.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$35	$41.33	$42	$47
Change	99.43%	135.50%	139.32%	167.81%

AI Analyst Report

According to 5 stock analyst, the rating for Bicara Therapeutics Inc. Common Stock is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating	Oct 24	Dec 24
Strong Buy	0	0
Buy	4	1
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	4	1

Financial Forecast this Year

No analyst forecast available for Bicara Therapeutics Inc. Common Stock.